SCHEMBL4377865

SCHEMBL4377865

O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCN(c2ccncc2)CC1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PANK3 Q9H999 2/20 0.63
▸ HRH3 Q9Y5N1 2/20 0.60
▸ ME2 P23368 3/20 0.57
▸ ME1 P48163 3/20 0.57
▸ ME3 Q16798 3/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ POLB P06746 1/20 0.55
▸ GFER P55789 3/20 0.54
▸ MAPT P10636 3/20 0.53
▸ KCNA5 P22460 1/20 0.51
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HPGD P15428 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383720 0.86 PANK3 (0.48) PANK3HRH3ME2ME1ME3
SCHEMBL4376118 0.86 HRH3 (0.60) HRH3ME2ME1ME3POLB
SCHEMBL4376289 0.81 ALDH1A1 (0.64) HRH3KCNA5ALDH1A1SMN1; SMN2
SCHEMBL7402423 0.81 USP2 (0.54) ME2ME1ME3L3MBTL1POLB
SCHEMBL17338907 0.80 HRH3 (0.64) PANK3HRH3MAPTKMT2ASMN1; SMN2
SCHEMBL18713212 0.80 HRH3 (0.71) PANK3HRH3L3MBTL1GFERMAPT
SCHEMBL14817940 0.80 GFER (0.68) ME2ME1ME3POLBGFER
SCHEMBL19506302 0.79 HRH3 (0.67) PANK3HRH3MAPTMEN1KMT2A
SCHEMBL18389821 0.78 HRH3 (0.72) PANK3HRH3MAPTMEN1KMT2A
SCHEMBL4375739 0.78 MAPT (0.64) HRH3ME2ME1ME3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 — — EP claimed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 — — EP disclosed
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 — — EP disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed
US-20080113968-A1 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2008-05-15 — — US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 — — US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 — — US disclosed
US-7208497-B2 Substituted piperazines and diazepanes NOVO NORDISK A/S (DK) 2007-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113968-A1 Substituted piperazines and diazepanes HRH3, HRH4, HRH1 PANK3 2534/4885HRH3 1/4885ME2 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback